News

Fagron's Successful Completion of Share Buy-Back Initiative

Fagron's Successful Completion of Share Buy-Back Initiative

Fagron's Share Buy-Back Program Completion

Fagron has recently concluded an important phase in its financial strategy with the successful completion of a share buy-back program. This initiative underscores the company's commitment to enhancing shareholder value and reinforcing its capital structure.

Details of the Buy-Back Program

Between 10 November 2025 and 14 November 2025, Fagron repurchased a total of 44,000 shares. The average price for these shares was €20.7208, resulting in an overall expenditure of approximately €911,717. In total, the company has repurchased 200,000 shares under this program, with an average price of €20.6805, leading to a cumulative investment of €4,136,093.

A Focus on Strategic Growth

This strategic move to buy back shares reflects Fagron's confidence in its long-term growth and its commitment to return value to shareholders. The shares acquired will be crucial for fulfilling obligations under Fagron’s incentive schemes, aligning the interests of employees and shareholders.

Background of the Program Announcement

The announcement of the buy-back program was made on 9 October 2025, highlighting Fagron's ongoing dedication to maintaining a robust balance sheet while actively pursuing avenues to boost shareholder confidence amidst a competitive market landscape.

Future Prospects for Fagron

As Fagron continues to evolve, it remains focused on its core mission of personalized medicine. The company strives to innovate and expand its offerings to hospitals, pharmacies, and clinics globally, thereby enhancing patient care and operational efficiency.

Upcoming Financial Calendar

Fagron has laid out a comprehensive financial calendar that outlines key upcoming events. Important dates to note include:

  • Full year results 2025: 12 February 2026
  • Trading update for first quarter 2026: 9 April 2026
  • Annual General Meeting 2025: 11 May 2026
  • Half year results 2026: 30 July 2026
  • Trading update for third quarter 2026: 8 October 2026

Company Information

Fagron is a leader in pharmaceutical compounding, dedicated to providing personalized medicine across more than 35 countries. With its base in Nazareth, the company operates under the ticker symbol ‘FAGR’ on Euronext Brussels and Amsterdam.

Contact Details

For further inquiries or information, please contact:

Ignacio Artola
Global Investor Relations Leader
Ignacio.artola@fagron.com

Frequently Asked Questions

What is the purpose of the share buy-back program?

The goal of the share buy-back program is to enhance shareholder value and support the company's long-term incentive schemes.

How many shares did Fagron buy back?

Fagron repurchased a total of 200,000 shares during the buy-back program.

What was the average price of shares purchased?

The average price of shares purchased during the program was approximately €20.6805.

When was the buy-back program announced?

The buy-back program was announced on 9 October 2025.

What are Fagron's core business focuses?

Fagron primarily focuses on pharmaceutical compounding and delivering personalized medicine to improve patient care worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

World Fire Congress 2026 Champions Global Fire Safety

Updated Category News Views 5

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

Continue Reading
Insurance Bad Faith: Navigating California's Rigorous Laws

Updated Category News Views 6

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
OneAscent Welcomes Monica Stoudemire as New CCO

Updated Category News Views 5

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 0

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 7

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 6

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading

Top 5 Most Recently Viewed Articles

How Recent Developments Boosted Bakkt Holdings Stock Price Sharply

Updated Category News Views 115

Exciting Growth for Bakkt Holdings Bakkt Holdings has recently seen an incredible surge in its stock price, which has nearly tripled in just a month. This remarkable growth can be attributed to rumors of a potential acquisition by Trump Media & Technology Group, linked to President-elect Donald Trump. Recent Stock Performance On a recent trading day, Bakkt closed at an...

Continue Reading
Nepsis Inc. Expands Operations with New Headquarters

Updated Category News Views 189

Nepsis Inc. Expands with New Headquarters Nepsis, Inc., a leading national financial advisory and investment firm, has proudly opened its new headquarters in a bustling business district. This expansion to Two Meridian represents a significant milestone for Nepsis, as it embraces growth and enhances its services. Location Advantages The new office, situated at the...

Continue Reading
Ultragenyx Pharmaceutical Expands Employee Incentives for Growth

Updated Category News Views 191

Ultragenyx Pharmaceutical's Commitment to Employee Growth In a recent development, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical leader focused on creating innovative therapies for rare and ultra-rare diseases, announced an employee incentive program designed to attract and retain top talent. This program includes the granting of non-qualified stock...

Continue Reading
Calgary Health Foundation Welcomes New Leadership and Vision

Updated Category News Views 221

Calgary Health Foundation Begins New Leadership Era The Calgary Health Foundation is entering a pivotal phase in its journey, honoring the remarkable contributions of outgoing President & CEO Murray Sigler while looking forward to a vibrant future with Paul Rossmann at the helm. This transition is targeted to take place on April 1, 2025. A Legacy of Impactful Leadership...

Continue Reading
Paren Raises $3M to Advance Electric Vehicle Innovations

Updated Category News Views 171

Paren Secures Significant Seed Funding for Electric Mobility Paren, an innovative data platform focused on electric mobility, has successfully secured $3 million in seed funding. Supported by Base10 Partners, this initial investment marks a significant step forward for the startup as it aims to enhance its offerings within the electric vehicle sector. Funding Details and...

Continue Reading